Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SUPN Supernus Pharmaceuticals

33.080
+0.140+0.43%
Close 09/23 16:00 ET
High
33.140
Open
32.910
Turnover
14.48M
Low
32.150
Pre Close
32.940
Volume
441.80K
Market Cap
1.77B
P/E(TTM)
32.75
52wk High
36.080
Shares
53.50M
P/E(Static)
33.76
52wk Low
24.950
Float Cap
1.60B
Bid/Ask %
-100.00%
Historical High
61.250
Shs Float
48.27M
Volume Ratio
0.85
Historical Low
4.300
Dividend TTM
--
Div Yield TTM
2000
P/B
2.10
Dividend LFY
--
Div Yield LFY
6045.95%
Turnover Ratio
0.92%
Amplitude
3.01%
Avg Price
32.765
Lot Size
1
Float Cap
1.60B
Bid/Ask %
-100.00%
Historical High
61.250
Shs Float
48.27M
Volume Ratio
0.85
Historical Low
4.300
Dividend TTM
--
P/B
2.10
Dividend LFY
--
Turnover Ratio
0.92%
Amplitude
3.01%
Avg Price
32.765
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.
CEO: Mr. Jack A. Khattar
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...